噬菌体呈现肽库技术的应用

噬菌体呈现肽库是噬菌体显示技术的一个非常重要的分支。自问世以来,随着分子生物学技术的飞速发展,它已被广泛应用于免疫学、分子生物学、药理学、疫苗学等生命科学领域。简要概述了这一技术的应用。     

家蚕核型多角体病毒遍在蛋白及结合肽的研究

从家蚕核型多角体病毒镇江株(Bombyx mori nuclear polyhedrosis virus Zhenjiang strain, BmNPV-ZJ)基因组DNA中克隆遍在蛋白（BmVUB）基因.序列分析结果显示,BmVUB基因长234 bp,编码77个氨基酸.BmVUB氨基酸序列内有一致HTH序列,遍在蛋白保守序列LRLRGG,参与遍在蛋白-蛋白酶复合体形成的4个保守性功能位点(Lys-29、Cys-48、Cys-63、Gly-76)及保守的Gly-Gly-X（X是疏水氨基酸残基）蛋白酶切信号序列,在遍在蛋白保守的Gly-Gly后多出由一个氨基酸组成的延伸肽.原核诱导表达表明BmVUB主要以可溶性形式存在,表达量占总菌蛋白的50%以上.纯化的遍在蛋白浓度为1.03～2.46 g/L,制备抗体,效价在3.2×10^-5以上.用噬菌体表面展示技术筛选遍在蛋白结合肽,所筛选的结合肽可与遍在蛋白特异性结合,其中结合肽VAPHHAYAPMRT对细胞增殖有明显的浓度调控作用,即低浓度促进细胞生长,高浓度强烈抑制细胞的生长.     

基于人HMGB1-B box的抑制性小肽筛选及其抗炎功能分析

目的从噬菌体构象型7肽库中筛选人HMGB1-Bbox的抑制性小肽。方法以重组人HMGB1-Bbox为靶分子对噬菌体构象型7肽库进行6轮亲和筛选,获得Bbox结合的克隆,并经ELISA验证。选取亲和力高的克隆进行DNA测序,并推导出呈现的多肽序列,通过IL-6 ELISA检测噬菌体呈现的小肽对人HMGB1-B box致炎功能的抑制作用。结果经过6轮亲和筛选,噬菌体的回收率增加,阳性克隆得到富集。挑选15个结合力强的克隆进行测序,推导出2个多肽序列。所获两个阳性噬菌体克隆能特异性地抑制人HMGB1-B box刺激THP-1细胞产生炎症因子的能力。结论获得了噬菌体呈现的能够抑制人HMGB1-B box的两个小肽。     

Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin

Fibronectin is an extracellular matrix protein with broad binding specificity to cell surface receptors, integrins. The tenth fibronectin type III domain (FNfn10) is a small, autonomous domain of fibronectin containing the RGE sequence that is directly involved in integrin binding. However, in isolation FNfn10 only weakly bind to integrins. We reasoned that high-affinity and high-specificity variants of FNfn10 to a particular integrin could be engineered by optimizing residues surrounding the integrin-binding RGD sequence in the flexible FG loop. Affinity maturation of FNfn10 to alphavbeta3 integrin, an integrin up-regulated in angiogenic endothelial cells and in some metastatic tumor cells, yielded alphavbeta3-binding FNfn10 mutants with a novel RGDWXE consensus sequence. We characterized one of the RGDWXE-modified clones, FNfn10-3JCLI4, as purified protein. FNfn10-3JCLI4 binds with high affinity and specificity to purified alphavbeta3 integrin. Alanine scanning mutagenesis suggested that both the tryptophan and glutamic acid residues following the RGD sequence are required for maximal affinity and specificity for alphavbeta3. FNfn10-3JCLI4 specifically stained alphavbeta3-positive cells as detected with flow cytometry and it inhibited alphavbeta3-dependent cell adhesion. As with the anti-alphavbeta3 antibody LM609, FNfn10-3JCLI4 can interfere with in vitro capillary formation. Taken together, these data show that FNfn10-3JCL14 is a specific, high-affinity alphavbeta3-binding protein that can inhibit alphavbeta3-dependent cellular processes similar to an anti-alphavbeta3 monoclonal antibody. These properties, combined with the small, monomeric, cysteine-free and highly stable structure of FNfn10-3JCLI4, may make this protein useful in future applications involving detection and targeting of alphavbeta3-positive cells.     

抗肿瘤小分子多肽的研究进展

抗肿瘤小分子多肽具有分子量小、低毒性、高活性、易于穿透肿瘤细胞等特点,一些抗肿瘤小分子多肽已进入临床研究,成为肿瘤药物研发的新热点。本文从抗肿瘤小分子多肽的不同来源途径、结构改造及生物活性等方面,对其近年来的研究进展作简要概述。     

多肽噬菌体展示

噬菌体展示技术已被广泛地应用于生物学研究的各个方面.利用它可融合表达多肽、蛋白质结构域和蛋白质.尤其是多肽噬菌体展示,已被作为一种便利的研究工具去发现和研究那些与受体、酶、凝集素、抗体、核酸以及其他生物分子亲和的多肽配基和酶的底物专一性,该技术在药物的发现,疫苗的设计等医学领域也有着潜在的应用价值.     

Generation of a naïve/synthetic antibody specific to botulinum neurotoxin via motif-grafting

In this study, we describe a new approach to the production of naïve/synthetic human antibodies against the botulinum neurotoxin (BoNT). First, peptides that bind to BoNT serotype A (BoNT/A) were screened from a phage display of a combinatorial peptide library. One peptide, designated ANT 12-2 (TLPSPLALLTVH), was determined to interact with BoNT/A, as well as with other serotypes of BoNT. This peptide specifically reacted with the native form of BoNT/A, but not with its formalin-inactivated form. Next, a hybrid naïve/synthetic human Fab library was generated via the grafting of a peptide motif from ANT 12-2 into HCDR3 with randomized flanking residues. Through biopanning, the Fab clone, ANTHU-1, which harbors the HCDR3 sequence of VRIQRSPLALLSWGDV, was selected and confirmed in order to retain the same BoNT-binding characteristics as ANT 12-2.     

从噬菌体随机肽库中筛选流感病毒神经氨酸酶的抑制多肽

目的:从噬菌体呈现12肽库中筛选与流感病毒神经氨酸酶特异性结合的肽。方法:以甲三型流感病毒裂解疫苗原液为靶分子,经过3轮生物淘选,从噬菌体随机肽库中筛选与之结合的噬菌体。用ELISA方法鉴定噬菌体克隆与靶分子的结合力,用荧光方法测定噬菌体克隆对流感病毒A/Sydney/5/97(H3N2)神经氨酸酶的抑制活性。对筛选到的阳性克隆进行DNA序列测定并推导出相应的氨基酸序列。结果:经过3轮筛选后,42个噬菌体克隆与靶分子有高度亲和力,23个噬菌体克隆对流感病毒A/Sydney/5/97(H3N2)神经氨酸酶有抑制活性。对27个噬菌体克隆的测序结果表明,分别有10个和2个克隆的序列是一致的,其氨基酸序列分别为KSLSRHDHIHHH和WPRHHHSASVQT。结论:通过噬菌体肽库筛选到抑制流感病毒神经氨酸酶的12肽,为进一步研究对流感病毒神经氨酸酶有抑制活性的分子药物奠定了基础。     

噬菌体肽库技术的应用

噬菌体肽库是由大量带有不同肽段的单个噬菌体组成的重组噬菌体库,通过分析筛选到的多肽的结构和序列,可以了解蛋白质分子之间的相互作用。随着生物技术的发展,噬菌体肽库技术在基因治疗、抗原表位定位、确定核酸结合蛋白、基因疫苗研究和药物筛选等方面得到广泛应用并取得了很大进展。     

人 Toll-like receptor 2 配基模拟肽的初步研究

TLR-2 (Toll-like receptor 2) 是介导天然免疫的重要模式识别分子,可参与识别多种病原体及其产物 . 为探索被 TLR-2 所识别配基的结构共性,以真核细胞表达的人 TLR-2 胞外段蛋白 (A26~T588) 为钓饵筛选噬菌体 12 肽库,获得一高度保守的阳性噬菌体克隆 P12-1 ,实验发现 P12-1 可与不同形式的 TLR-2 胞外段结合,并且可刺激细胞分泌 TNFα,提示 P12-1 可能模拟 TLR-2 配基的结构与生物学活性 .     

Identification of inorganic crystal-specific sequences using phage display combinatorial library of short peptides: A feasibility study

The feasibility of using a combinatorial phage display library of decapeptides to identify ligands which can interact with the surface of a crystal was assessed using geological calcium carbonate as a model. Two relatively strong binding clones were identified by ELISA, sequenced and the encoded oligopeptides were prepared by solid phase synthesis and their properties compared with those of casein hydrolysate.     

交替洗脱法筛选高亲和力噬菌体肽

以人胰岛素为靶蛋白从七肽展示库中筛选高亲和力噬菌体肽,在洗脱阶段采用酸性洗脱液和高浓度靶蛋白溶液进行4次交替洗脱,选择性回收高亲和力噬菌体肽。测定滴度计算回收率,ELISA法分别测定噬菌体洗脱液整体亲和力和噬菌体单克隆的结合特性并计算亲合率。洗脱步骤采用4次交替洗脱后,第二轮第4次噬菌体的回收率比第一轮增长了1800倍,高亲和力噬菌体在洗脱液中所占比例也迅速提高,第二轮第4次洗脱液中达75％,在第三轮的各次洗脱液中几乎均达100％。建立了一种快速筛选高亲和力噬菌体肽的方法,改进后的筛选方法能使高亲和力噬菌体肽的筛选工作更为简便且效果显著。     

以GST融合蛋白为靶从噬菌体肽库中筛选结合肽

以重组的谷胱甘肽S-转移酶（GST）和目标蛋白的融合蛋白为靶,通过将其固定于谷胱甘肽琼脂糖凝胶上,可以方便地从噬菌体肽库中筛选目标蛋白的结合肽.用此方法筛选到含WWXF结构的HIV-1病毒蛋白R（Vpr）的结合肽,与经典的将Vpr包被于培养板上的筛选方法相比,此方法具有简便、快速的优点.     

利用噬菌体展示肽库筛选鸡传染性支气管炎病毒模拟抗原表位

目的：利用噬菌体展示肽库技术筛选鸡传染性支气管炎病毒（IBV）的模拟抗原表位。方法：用IBV阳性血清纯化IgG作为靶标。对噬菌体展示随机12肽库进行筛选，通过ELISA和竞争抑制ELISA鉴定筛选克隆的结合特性，并对阳性克隆提取ssDNA进行测序分析。结果：3轮生物淘洗后，目标噬菌体得到125倍富集。随机挑选50个克隆进行ELISA和竞争抑制ELISA。其中有12个噬菌体克隆可以与IBV阳性血清高特异性结合。测序分析发现，这12个克隆带有2种氨基酸序列。即KSPKHSSSALHF和SFFQLNLHRPTS。且未发现这2种序列与GenBank中已发表的IBV氨基酸序列有同源性。结论：结果提示。这2个肽可能是IBV抗原的模拟表位。